AmpliTech Group, Inc. (AMPG) — Fundamental Analysis
Snapshot & Big Picture
AmpliTech Group, Inc. designs and manufactures signal-processing components and systems — primarily RF amplifiers and related technologies — serving aerospace, defense, telecommunications, and commercial markets. The company has been on an aggressive growth path through organic expansion and acquisitions, most notably its purchase of Specialty Microwave Corporation, which significantly enlarged its revenue base. As of the most recently completed fiscal year (FY2025, ending December 31, 2025), AMPG reported $25.2 million in annual revenue, its highest on record. However, sustained profitability has remained elusive, with the company posting operating and net losses in most years of its public history.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $25,195,930 | $9,508,372 | $15,584,577 | $19,394,492 |
| Gross Margin | 23.9% | 36.7% | 46.7% | 46.0% |
| Operating Margin | -29.1% | -88.7% | -16.5% | 0.8% |
| Net Margin | -27.8% | -118.2% | -15.8% | -3.5% |
| EBITDA | -$6,027,348 | -$7,891,228 | -$2,046,376 | $562,963 |
| Current Ratio | 1.68 | 18.45 | 11.44 | 5.52 |
Latest Quarter Snapshot (Q1 2026 — Most Current Data Available)
The most recent quarterly filing covers the period ending March 31, 2026, and represents the freshest available data — more current than the annual figures above. AMPG reported quarterly revenue of $5,349,446, implying an annualized run rate roughly in line with, though slightly below, the FY2025 full-year pace.
| Metric | Q1 2026 (Period Ending Mar 31, 2026) |
|---|---|
| Revenue | $5,349,446 |
| Gross Margin | 48.0% |
| Operating Margin | -30.3% |
| Net Margin | -28.4% |
| EBITDA | -$1,086,724 |
| Current Ratio | 4.25 |
| Debt-to-Equity | 0.024 |
| Capital Expenditures | $361,045 |
| CapEx-to-Revenue | 6.7% |
Notably, Q1 2026's gross margin of 48.0% is a meaningful rebound from the full-year FY2025 figure of 23.9%, suggesting that the margin compression seen in FY2025 may be easing. The company remains unprofitable at the operating and net levels, and the operating loss margin of -30.3% indicates that overhead and operating costs continue to significantly outpace gross profit dollars at this revenue scale.
Profitability
AMPG's profitability track record is mixed and largely negative. In its earlier years as a smaller, organically-growing business (FY2016–FY2019), the company actually posted respectable gross margins in the 50–59% range and occasional positive EBITDA and net income. The transformative shift came with acquisitions that boosted revenue but also dramatically increased the cost structure.
| Fiscal Year | Revenue | Gross Margin | Operating Margin | Net Margin | EBITDA |
|---|---|---|---|---|---|
| FY2025 | $25,195,930 | 23.9% | -29.1% | -27.8% | -$6,027,348 |
| FY2024 | $9,508,372 | 36.7% | -88.7% | -118.2% | -$7,891,228 |
| FY2023 | $15,584,577 | 46.7% | -16.5% | -15.8% | -$2,046,376 |
| FY2022 | $19,394,492 | 46.0% | 0.8% | -3.5% | $562,963 |
| FY2021 | $5,275,434 | 24.5% | -96.8% | -90.2% | -$4,958,800 |
| FY2020 | $3,458,081 | 36.3% | -26.5% | -29.7% | -$824,109 |
| FY2019 | $3,122,630 | 50.1% | 2.6% | 0.2% | $135,876 |
| FY2018 | $2,397,418 | 57.6% | 14.2% | 13.7% | $380,245 |
| FY2017 | $1,380,743 | 52.7% | -6.5% | -7.0% | -$63,233 |
| FY2016 | $2,036,443 | 59.4% | 23.2% | 22.4% | $500,775 |
| FY2015 | $1,484,793 | 49.4% | 5.8% | 3.4% | $116,184 |
The trend is concerning from a profitability standpoint. Gross margins have compressed sharply — from the 46–47% range in FY2022–FY2023 down to 23.9% in FY2025 — suggesting the new revenue mix carries substantially higher costs of goods sold, possibly reflecting the nature of the acquired business or pricing pressure. FY2022 was the only recent year AMPG came close to operating breakeven. FY2024 was the worst year on record by margin metrics, with a net loss exceeding its revenue. The Q1 2026 gross margin recovery to ~48% is an encouraging data point, but it is a single quarter and profitability at the bottom line remains deeply negative.
Financial Health
AMPG's balance sheet liquidity has generally been adequate, though it fluctuated significantly. The current ratio stood at a very high 18.45x in FY2024, likely reflecting a capital raise or reduced current liabilities, before normalizing to 1.68x in FY2025 — still above 1.0x, indicating current assets exceed current liabilities. As of Q1 2026, the current ratio was 4.25x, a meaningful improvement from year-end FY2025.
Debt-to-equity has been minimal or not reported in most periods. In FY2020 it was elevated at 3.64x, likely reflecting early-stage debt financing. It dropped to near zero in FY2022 (0.008x) and FY2023 (0.003x), and was not available (null) in several years including FY2021, FY2024, and FY2025 annual filings — meaning it was not determinable from those filings, possibly due to negative equity or zero debt. As of Q1 2026, debt-to-equity was a modest 0.024x, suggesting very little financial leverage.
Capital Expenditures
Capital spending has been variable across AMPG's history. Note that FY2015 CapEx data was not available in that year's filing.
| Fiscal Year | Capital Expenditures | CapEx-to-Revenue |
|---|---|---|
| FY2025 | $1,015,710 | 4.0% |
| FY2024 | $42,920 | 0.5% |
| FY2023 | $973,349 | 6.2% |
| FY2022 | $735,761 | 3.8% |
| FY2021 | $1,063,676 | 20.2% |
| FY2020 | $71,619 | 2.1% |
| FY2019 | $12,653 | 0.4% |
| FY2018 | -$10,584 | -0.4% |
| FY2017 | $5,371 | 0.4% |
| FY2016 | $14,335 | 0.7% |
| FY2015 | Not available in filing | Not available in filing |
| Q1 2026 | $361,045 | 6.7% |
Capital intensity was very low in AMPG's early years (sub-1% of revenue), spiked dramatically in FY2021 (20.2% of revenue) during an apparent investment phase post-acquisition, then moderated to the 4–6% range in FY2022–FY2023. FY2024 saw a dramatic pullback to just $42,920 — essentially minimal reinvestment — before rebounding to $1,015,710 in FY2025. The Q1 2026 CapEx of $361,045 (6.7% of quarterly revenue) suggests reinvestment activity is back at a more active level. Overall, capital intensity appears moderate for a manufacturing/components business, though the inconsistency year-to-year makes it difficult to identify a clear reinvestment strategy. The FY2024 near-zero CapEx may reflect capital conservation during a difficult revenue year.
Growth
| CAGR Window | Start Fiscal Year | End Fiscal Year | Start Revenue | End Revenue | Revenue CAGR |
|---|---|---|---|---|---|
| 3-Year | FY2022 | FY2025 | $19,394,492 | $25,195,930 | 9.1% |
| 5-Year | FY2020 | FY2025 | $3,458,081 | $25,195,930 | 48.8% |
| 10-Year | FY2015 | FY2025 | $1,484,793 | $25,195,930 | 32.7% |
The 5-year CAGR of 48.8% is eye-catching but largely reflects the step-change from acquisitions — the company's revenue base in FY2020 was only $3.5 million, making the math favorable. The more telling figure may be the 3-year CAGR of 9.1%, which spans the post-acquisition period (FY2022–FY2025) and shows that organic growth from the enlarged base has been relatively modest, with revenue actually declining from FY2022 to FY2023 and FY2024 before recovering to a new high in FY2025. The 10-year CAGR of 32.7% reflects the company's full transformation from a micro-cap RF components shop to its current scale.
Plain English Summary
AmpliTech Group is a small RF components and systems manufacturer that has grown rapidly through acquisitions, ballooning its revenue from under $4 million in FY2020 to over $25 million in FY2025. On the surface, that growth story is impressive — a 5-year revenue CAGR approaching 49%. But the harder reality is that the company has struggled to translate that growth into profits. Gross margins have compressed significantly as the product mix shifted, and operating losses have persisted in nearly every year of its recent history. FY2024 was particularly rough, with the company losing more than a dollar for every dollar of revenue it earned. FY2025 brought a revenue recovery to record levels, but margins remained depressed. The silver lining heading into 2026 is that Q1 gross margins rebounded sharply to ~48%, suggesting the cost structure may be improving. The balance sheet appears reasonably healthy — minimal debt, current ratios above 1.0x — and capital expenditures are modest for a manufacturing business. Still, AMPG is fundamentally a pre-profitability story at this stage: investors are betting on the company reaching a scale where its operating costs are covered by the revenue it generates. That inflection point has not arrived yet, and the timeline remains unclear based on available data.

Leave a Comment